The Pursuer Pursued

      In this medical tale, a serious chronic condition may have offered protection against an additional life-threatening disease. A 49-year-old white male, who had undergone a cadaveric renal transplantation 4 months earlier, presented to the emergency department with a 3-day history of subjective fever, nausea, vomiting, and diarrhea. He also reported worsening shortness of breath and a dry cough, both of which began 1 day earlier. His post-transplantation period was uneventful, except for a Pseudomonas species skin infection 2 weeks prior to this presentation. The patient’s immunosuppressive regimen consisted of prednisone, 10 mg/day and tacrolimus, 5mg/day.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Peters C.J.
        • Khan A.S.
        Hantavirus pulmonary syndrome: the new American hemorrhagic fever.
        Clin Infect Dis. 2002; 34: 1224-1231
        • Muranyi W.
        • Bahr U.
        • Zeier M.
        • van der Woude F.J.
        Hantavirus infection.
        J Am Soc Nephrol. 2005; 16: 3669-3679
        • Centers for Disease Control and Prevention
        Case information: hantavirus pulmonary syndrome case count and descriptive statistics.
        (Accessed March 1, 2007)
        • Khaiboullina S.F.
        • Morzunov S.P.
        • St Jeor S.C.
        Hantaviruses: molecular biology, evolution and pathogenesis.
        Curr Mol Med. 2005; 5: 773-790
        • Peters C.J.
        • Simpson G.L.
        • Levy H.
        Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome.
        Annu Rev Med. 1999; 50: 531-545
        • Borges A.A.
        • Campos G.M.
        • Moreli M.L.
        • et al.
        Hantavirus cardiopulmonary syndrome: immune response and pathogenesis.
        Microbes Infect. 2006; 8: 2324-2330
        • Gasparetto E.L.
        • Davaus T.
        • Escuissato D.L.
        • Marchiori E.
        Hantavirus pulmonary syndrome: high-resolution CT findings in one patient.
        Br J Radiol. 2007; 80: e21-e23
        • Mori M.
        • Rothman A.L.
        • Kurane I.
        • et al.
        High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome.
        J Infect Dis. 1999; 179: 295-302
        • Schulak J.A.
        Steroid immunosuppression in kidney transplantation: a passing era.
        J Surg Res. 2004; 117: 154-162
        • Reedy J.L.
        • Husain S.
        • Ison M.
        • et al.
        Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients.
        Antimicrob Agents Chemother. 2006; 50: 1573-1577
        • Blazik M.
        • Hutchinson P.
        • Jose M.D.
        • et al.
        Leukocyte phenotype and function predicts infection risk in renal transplant recipients.
        Nephrol Dial Transplant. 2005; 20: 2226-2230